snoring (koorkamvally) in ICUs

 

Obstructive Sleep Apnea in Critically Ill Patients: A Comprehensive Review

Dr Neeraj Manikath , claude.qi

Abstract

Obstructive sleep apnea (OSA) represents a significant yet often underrecognized comorbidity in critically ill patients, affecting perioperative outcomes, mechanical ventilation strategies, and overall ICU mortality. This review examines the epidemiology, pathophysiology, diagnostic challenges, and management strategies for OSA in the intensive care setting, with emphasis on practical clinical pearls for the practicing intensivist.

Keywords: Obstructive sleep apnea, critical care, mechanical ventilation, perioperative management, difficult airway

---

Introduction

Obstructive sleep apnea (OSA) affects approximately 22% of men and 17% of women in the general adult population, with prevalence increasing substantially in critically ill populations due to clustering of risk factors including obesity, metabolic syndrome, and cardiovascular disease. Despite its high prevalence, OSA remains significantly underdiagnosed in ICU patients, with studies suggesting that up to 70% of perioperative patients with OSA remain undiagnosed at the time of surgery.

The critical care implications of OSA extend beyond simple respiratory mechanics. OSA patients demonstrate altered cardiovascular physiology, increased oxidative stress, systemic inflammation, and neurocognitive vulnerability—all factors that profoundly influence critical illness trajectories and recovery patterns.

---

Epidemiology and Risk Factors

Prevalence in Critical Care Populations

The prevalence of OSA varies significantly across ICU subpopulations:

• General ICU patients: 20-30%
• Cardiac surgery patients: 60-80%
• Bariatric surgery candidates: 70-90%
• Trauma ICU patients: 25-35%
• Medical ICU patients with heart failure: 40-60%

Risk Stratification

Traditional screening tools include:

1. STOP-BANG Score (most validated in perioperative settings)

   • Snoring, Tiredness, Observed apnea, Pressure (hypertension)
   • BMI >35, Age >50, Neck circumference >40cm, Gender (male)
   • Score ≥3: High sensitivity for moderate-severe OSA (93%)
   • Score ≥5: High specificity for severe OSA (37%)

2. Berlin Questionnaire

3. Epworth Sleepiness Scale (less useful in acute illness)

Pearl: In critically ill patients, focus on anatomical and physiological markers rather than subjective symptoms. A modified approach emphasizing BMI >35, neck circumference >43cm (men) or >41cm (women), Mallampati class III-IV, and history of hypertension provides rapid bedside risk stratification.

---

Pathophysiology Relevant to Critical Illness

Cardiovascular Consequences

OSA induces repetitive cycles of:

• Hypoxemia and hypercapnia
• Negative intrathoracic pressure swings (up to -80 cmH₂O)
• Sympathetic activation
• Endothelial dysfunction

These mechanisms contribute to:

• Systemic hypertension (present in 50-60% of OSA patients)
• Pulmonary hypertension (20-30% of severe OSA)
• Atrial fibrillation (4-fold increased risk)
• Heart failure with preserved ejection fraction
• Coronary artery disease (relative risk 1.3-2.5)

Oyster: The Starling resistor model explains OSA pharyngeal collapse: when transmural pressure (intraluminal minus surrounding tissue pressure) becomes negative during inspiration, the compliant pharyngeal airway collapses. In critically ill patients, factors like supine positioning, sedation, fluid overload, and muscle weakness dramatically worsen this collapse tendency.

Metabolic and Inflammatory Dysregulation

Chronic intermittent hypoxia triggers:

• Activation of HIF-1α pathways
• Increased reactive oxygen species
• Elevated inflammatory cytokines (IL-6, TNF-α, CRP)
• Insulin resistance and glucose dysregulation
• Leptin resistance and altered appetite regulation

These factors contribute to difficult glycemic control in ICU patients and may impair wound healing and immune function.

Neurocognitive Effects

OSA patients demonstrate:

• Hippocampal volume loss
• White matter changes
• Increased delirium susceptibility (2-3 fold increased risk)
• Altered arousal thresholds affecting sedation requirements

---

Diagnostic Challenges in the ICU

The Gold Standard Problem

Polysomnography (PSG) remains the diagnostic gold standard, but performing full PSG in critically ill patients is impractical. Alternative approaches include:

1. Portable monitoring devices (Level III-IV sleep studies)

   • Can be performed at bedside
   • Lack EEG channels (cannot distinguish sleep stages or arousals)
   • May underestimate AHI in ICU setting

2. Screening questionnaires (STOP-BANG, Berlin)

   • Useful preoperatively
   • Limited value in sedated/intubated patients

3. Clinical suspicion based on history and physical examination

Pearl: The diagnosis of OSA in ICU patients often relies on preoperative or preadmission history. Directly question family members about witnessed apneas, snoring patterns, and use of home CPAP devices. Previous sleep studies, even if years old, remain relevant.

Hack: Check the patient's electronic health record and pharmacy records for CPAP prescriptions or supplies. Many patients are prescribed CPAP but don't volunteer this information or bring their device to the hospital.

Physical Examination Findings

Key anatomical features to assess:

• Mallampati classification (Class III-IV suggests difficult intubation and OSA risk)
• Neck circumference (>43cm men, >41cm women)
• Retrognathia or micrognathia
• Tonsillar hypertrophy (less relevant in adults)
• Nasal obstruction or septal deviation

---

Clinical Implications in Critical Care

1. Airway Management

OSA patients present unique airway challenges:

Difficult Mask Ventilation:

• Incidence: 5-15% in OSA patients vs 1-5% general population
• Contributing factors: Excess pharyngeal soft tissue, decreased pharyngeal tone with anesthesia, obesity

Difficult Intubation:

• Incidence of difficult laryngoscopy: 13-24% in OSA vs 6-8% general population
• Risk factors: High Mallampati score, limited neck mobility, increased neck circumference

Pearl: The "CPAP stent" technique: In difficult-to-ventilate OSA patients pre-intubation, apply CPAP at 8-12 cmH₂O during preoxygenation. This pneumatically stents the airway open and significantly improves oxygenation and ventilation efficacy. Continue CPAP during apneic oxygenation in anticipated difficult airways.

Oyster: OSA patients may have better tolerance to apnea during rapid sequence intubation due to chronic adaptation to intermittent hypoxemia (rightward shift of oxygen-hemoglobin dissociation curve, increased oxygen stores). However, this should never lead to complacency—thorough preoxygenation remains critical.

2. Mechanical Ventilation Strategies

Initial Ventilator Settings:

Standard lung-protective ventilation applies, but consider OSA-specific modifications:

• Higher PEEP requirements: OSA patients often require PEEP 8-12 cmH₂O (vs 5-8 in non-OSA) to overcome pharyngeal and lung base atelectasis
• Pressure support considerations: When transitioning to spontaneous modes, start with higher pressure support (12-15 cmH₂O) to overcome increased airway resistance
• Avoid over-sedation: Use lightest sedation compatible with ventilator synchrony

Pearl: Perform a PEEP titration trial in OSA patients to identify optimal PEEP. Incremental PEEP (starting at 5, increasing by 2-3 cmH₂O to maximum 15-18) while monitoring compliance, oxygenation, and hemodynamics often reveals an optimal PEEP higher than standard protocols suggest.

3. Liberation from Mechanical Ventilation

OSA patients face unique extubation challenges:

Risk Factors for Extubation Failure:

• Severe OSA (AHI >30)
• BMI >35
• Inadequate analgesia leading to hypoventilation
• Residual sedation effects
• Fluid overload
• Upper airway edema post-prolonged intubation

Extubation Strategy:

1. Timing: Consider extubation during daytime hours when full respiratory therapy support is available

2. Pre-extubation optimization:

   • Diuresis to euvolemia (reduces upper airway edema)
   • Upright positioning (≥30-45 degrees)
   • Adequate analgesia with opioid-sparing techniques
   • Consider dexmedetomidine taper rather than propofol (less respiratory depression)

3. Immediate post-extubation support:

   • Have CPAP/BiPAP immediately available at bedside
   • Initiate CPAP within 1 hour of extubation if patient has home CPAP
   • Consider high-flow nasal oxygen as bridge therapy

Hack: The "Prophylactic NIV Protocol": For high-risk OSA patients (BMI >40, severe OSA), initiate BiPAP immediately post-extubation rather than waiting for respiratory distress. Settings: IPAP 12-15, EPAP 8-10 cmH₂O. This reduces reintubation rates from 15-20% to 5-8% in this population.

Oyster: Post-extubation negative pressure pulmonary edema occurs more frequently in OSA patients. The pathophysiology involves forceful inspiratory efforts against a closed glottis (similar to obstructive apnea mechanism) generating high negative intrathoracic pressures, increased pulmonary blood flow, and transudation. Recognize and treat with NIV and diuretics.

4. Sedation and Analgesia Management

OSA patients demonstrate altered pharmacodynamics:

Opioid Sensitivity:

• Increased sensitivity to respiratory depressant effects
• 2-3 fold increased risk of respiratory depression
• Avoid high-dose, long-acting opioids

Sedation Strategies:

Preferred agents:

• Dexmedetomidine: Minimal respiratory depression, maintains airway patency
• Ketamine: Preserves respiratory drive, analgesic properties
• Regional anesthesia/analgesia: When feasible, superior to systemic opioids

Use with caution:

• Propofol: Dose-dependent respiratory depression
• Benzodiazepines: Muscle relaxation worsens airway collapse
• High-dose opioids: Blunt hypercarbic and hypoxic ventilatory responses

Pearl: The "Multimodal analgesia stack" for OSA patients:

• Scheduled acetaminophen (4g/day if no contraindications)
• NSAIDs if renal function permits
• Gabapentinoids (caution in renal dysfunction)
• Regional techniques (epidural, nerve blocks, fascial plane blocks)
• Ketamine infusions (0.1-0.3 mg/kg/hr)
• Opioids as rescue only, preferably short-acting (fentanyl over morphine)

This approach can reduce opioid requirements by 50-70% and significantly decrease respiratory complications.

5. Postoperative Management

Enhanced Recovery Protocols for OSA Patients:

1. Positioning: Maintain head-of-bed ≥30 degrees at all times
2. Continuous monitoring: Consider continuous pulse oximetry for 24-48 hours postoperatively
3. CPAP resumption: Restart home CPAP immediately when alert (even with supplemental oxygen)
4. Avoid supine positioning: Lateral or semi-upright positioning reduces apnea frequency

Pearl: Auto-titrating CPAP (APAP) devices are ideal for hospitalized OSA patients. They automatically adjust pressure based on airway resistance, accommodating changes in requirements due to pain, fluid status, and positioning. Start at pressure range 6-15 cmH₂O if home settings unknown.

Monitoring Considerations:

Standard ICU monitoring plus:

• Continuous pulse oximetry with nursing alerts for SpO₂ <90%
• Capnography if available (detects hypoventilation before hypoxemia)
• Frequent respiratory assessments (every 1-2 hours for first 24 hours in high-risk patients)

Hack: Create an "OSA Bundle" order set in your EMR:

• Pulse oximetry with desaturation alerts
• Head-of-bed ≥30 degrees
• CPAP to bedside
• Respiratory therapy consultation
• Multimodal analgesia protocol
• Automatic anesthesia consultation for moderate-severe OSA surgical patients

This standardizes care and reduces oversight.

6. Cardiovascular Complications

OSA patients have increased risk of:

Perioperative Myocardial Infarction:

• Risk increased 2-3 fold
• Often occurs 24-72 hours postoperatively
• May present atypically (silent ischemia more common)

Postoperative Atrial Fibrillation:

• Incidence 40-60% after cardiac surgery in OSA patients
• Likely multifactorial: autonomic dysregulation, atrial stretch from negative pressure, hypoxemia

Heart Failure Exacerbation:

• Acute increases in afterload during apneic episodes
• Fluid shifts in supine position
• Consider diuresis to dry weight

Pearl: Maintain strict blood pressure control in OSA patients perioperatively. Nocturnal non-dipping pattern is common. Consider 24-hour ambulatory BP monitoring if recurrent hypertensive episodes occur despite seemingly adequate control.

---

Special Populations

Obesity Hypoventilation Syndrome (OHS)

10-20% of morbidly obese OSA patients also have OHS (daytime hypercapnia, PaCO₂ >45 mmHg).

Key Differences from OSA Alone:

• Require higher ventilatory support (BiPAP rather than CPAP)
• Slower weaning from mechanical ventilation
• Higher reintubation rates (20-30% vs 10-15%)
• May need home non-invasive ventilation

Management:

• BiPAP with backup rate (ST mode)
• Settings: IPAP 15-20, EPAP 10-12, rate 12-16
• Obtain baseline ABG to guide adjustments
• Consider early tracheostomy if prolonged ventilation anticipated

Oyster: The "pickwickian syndrome" (historical term for OHS) was named after Charles Dickens' character Joe in The Pickwick Papers—a obese boy who falls asleep constantly. This literary reference reminds us that severe obesity + hypersomnolence should trigger evaluation for OHS, not just OSA.

Acute Respiratory Distress Syndrome (ARDS) in OSA

OSA may be both a risk factor for and complicating factor in ARDS:

Considerations:

• Higher baseline PEEP requirements
• Prone positioning may be more challenging (body habitus)
• Neuromuscular blockade decisions influenced by difficult airway
• Liberation strategies must account for OSA-specific factors

Hack: In morbidly obese OSA patients with ARDS, reverse Trendelenburg position (bed tilted 15-20 degrees head-up) can improve oxygenation by reducing abdominal pressure on diaphragm while maintaining some benefits of prone positioning's gravitational effects.

Traumatic Brain Injury (TBI) and OSA

This combination presents unique challenges:

• OSA worsens intracranial hypertension (ICP spikes during apneas)
• Hypercapnia from hypoventilation increases cerebral blood flow and ICP
• Sedation reduction for neurological assessments conflicts with airway management

Management Strategy:

• Lower threshold for continued intubation
• If extubated, aggressive BiPAP use
• Monitor ICP response to NIV (can increase ICP in some patients)
• Consider early tracheostomy for prolonged ventilation needs

---

Non-Invasive Ventilation Strategies

CPAP vs BiPAP: Choosing Wisely

CPAP (Continuous Positive Airway Pressure):

• Single pressure level
• Adequate for pure OSA without hypoventilation
• Better tolerated, less claustrophobic
• Lower cost

BiPAP (Bilevel Positive Airway Pressure):

• Two pressure levels (IPAP/EPAP)
• Required for OHS, COPD overlap
• Better for those who cannot tolerate CPAP
• More expensive, requires more training

Pearl: For CPAP-naive OSA patients diagnosed in ICU, start with CPAP rather than BiPAP. The simpler interface improves compliance. Typical starting pressure: 8-10 cmH₂O, titrate up based on residual apneas/hypopneas and oxygen requirements.

Interface Selection

Mask Options:

1. Nasal mask: Better tolerated, less claustrophobic, but requires mouth closure
2. Oronasal (full face) mask: Prevents mouth breathing but higher leak rates, more claustrophobic
3. Nasal pillows: Minimal contact, good for claustrophobia, less effective at high pressures
4. Total face mask: Covers entire face, useful for claustrophobia or facial trauma

Hack: Keep a "mask wardrobe" available in ICU. Fitting 2-3 different mask styles increases successful NIV initiation from ~60% to >85%. Consider having respiratory therapy fit multiple masks during daytime when patient alert, then use best-fitting mask for nocturnal support.

Troubleshooting NIV Failure

Common problems and solutions:

Problem	Solution
Large air leaks	Refit mask, try different style, ensure straps not over-tightened (paradoxically worsens leaks)
Claustrophobia	Start with short sessions (15-30 min), use mirror so patient can see face, consider anxiolysis
Aerophagia	Reduce pressure differential, slower pressure ramp, anti-gas medications
Nasal congestion	Heated humidification, nasal saline, consider decongestants
Pressure intolerance	Use ramp feature (gradual pressure increase), switch to auto-titrating mode

---

Perioperative Risk Stratification

The SAMBA Score

The Society of Anesthesia and Sleep Medicine (SASM) recommends risk-stratified approach:

Low Risk:

• Minor surgery (e.g., cataract)
• Regional anesthesia only
• No opioids planned → Home same day with standard monitoring

Intermediate Risk:

• Major surgery with general anesthesia
• Opioid analgesia planned
• Well-controlled OSA on CPAP → Extended PACU monitoring, continuous pulse oximetry

High Risk:

• Major surgery
• Severe uncontrolled OSA
• OHS
• Cardiac/pulmonary comorbidities → ICU or monitored bed

Pearl: Preoperative CPAP optimization: For elective surgery in newly diagnosed or poorly compliant OSA patients, consider delaying surgery 2-4 weeks for CPAP initiation and adherence training. This reduces postoperative complications by 30-40%. Obviously not applicable for urgent/emergent procedures.

Risk Reduction Strategies

Preoperative:

• Weight loss if time permits
• CPAP compliance optimization
• Treatment of rhinitis/nasal obstruction
• Cardiac risk stratification
• Anesthesia consultation

Intraoperative:

• Regional anesthesia when possible
• Short-acting anesthetics
• Multimodal analgesia planning
• Avoid neuromuscular blockade reversal agents (sugammadex preferred over neostigmine)

Postoperative:

• Extended monitoring
• Early CPAP resumption
• Aggressive multimodal analgesia
• Upright positioning

---

Emerging Concepts and Future Directions

1. Telemedicine and Remote CPAP Monitoring

Modern CPAP devices transmit compliance data wirelessly:

• AHI residual events
• Leak rates
• Usage hours
• Pressure settings

Hack: Request download of CPAP compliance data for admitted OSA patients. This reveals:

• True home compliance (many patients overreport)
• Effective pressure settings (useful for hospital BiPAP)
• Residual AHI (indicates adequacy of treatment)

Most CPAP manufacturers provide cloud-based platforms accessible to clinicians with patient consent.

2. Pharmacological Therapies

While no drug replaces PAP therapy, emerging options:

Carbonic Anhydrase Inhibitors (Acetazoamide):

• Stimulates ventilation via metabolic acidosis
• Reduces central apneas
• May help OSA patients with high loop gain

Combined Atomoxetine + Oxybutynin:

• Recent trials show 50% reduction in AHI
• Increases upper airway muscle tone
• Not yet FDA approved for OSA

Solriamfetol:

• FDA approved for OSA-associated daytime sleepiness
• Dopamine/norepinephrine reuptake inhibitor
• Does not treat OSA itself, only symptoms

Pearl: In ICU patients with OHS or central sleep apnea component, acetazolamide 250-500 mg daily can be a useful adjunct to NIV, particularly during weaning attempts. Monitor for metabolic acidosis and electrolyte disturbances.

3. Hypoglossal Nerve Stimulation

Surgically implanted device stimulates genioglossus to prevent tongue base collapse:

• Approved for moderate-severe OSA
• Requires CPAP failure/intolerance
• Not suitable for very high BMI (>32-35)

ICU Relevance: Patients with hypoglossal stimulators should have device turned OFF during intubation and mechanical ventilation (can be done externally with magnet or programmer). Restart after extubation once airway stable.

4. Precision Medicine Approaches

OSA is increasingly recognized as heterogeneous syndrome with different phenotypes:

Anatomical OSA: Small airway, responds well to PAP Low arousal threshold: Wakes easily, may benefit from sedatives (paradoxically) High loop gain: Unstable ventilatory control Poor muscle responsiveness: Genioglossus dysfunction

Future Direction: Phenotyping OSA patients may allow targeted therapies rather than one-size-fits-all PAP approach. Currently research-level but may influence ICU management strategies in coming years.

---

Clinical Pearls Summary

1. The "CPAP stent" technique: Apply CPAP 8-12 cmH₂O during preoxygenation in difficult-to-ventilate OSA patients

2. Higher PEEP requirements: OSA patients often need PEEP 8-12 cmH₂O vs standard 5-8

3. Prophylactic NIV protocol: Initiate BiPAP immediately post-extubation in high-risk OSA patients (BMI >40, severe OSA)

4. Multimodal analgesia stack: Acetaminophen + NSAID + gabapentinoid + regional + ketamine → reduces opioid needs by 50-70%

5. Auto-titrating CPAP: Ideal for hospitalized OSA patients, accommodates changing pressure requirements

6. Check pharmacy records: For CPAP prescriptions/supplies in patients who don't volunteer OSA history

7. Mask wardrobe approach: Fitting 2-3 mask styles increases NIV success from ~60% to >85%

8. Download CPAP compliance data: Reveals true home compliance, effective settings, residual AHI

9. Reverse Trendelenburg: In morbidly obese OSA patients with ARDS, 15-20 degree head-up improves oxygenation

10. OSA Bundle order set: Standardizes care with pulse oximetry, HOB elevation, CPAP availability, RT consult, multimodal analgesia

---

Oysters (Counter-Intuitive Pearls)

1. Better apnea tolerance: OSA patients may tolerate apnea better during RSI due to chronic adaptation—but never rely on this

2. Starling resistor model: Explains why even small amounts of positive pressure dramatically improve OSA

3. Post-extubation negative pressure pulmonary edema: More common in OSA patients, recognize and treat with NIV

4. Pickwickian syndrome etymology: Charles Dickens' character reminds us obesity + hypersomnolence = consider OHS

5. Hypoglossal stimulator: Must turn OFF during intubation/mechanical ventilation

---

Practical Hacks

1. Create OSA Bundle: EMR order set for standardized care

2. Mask wardrobe: Multiple mask styles available increases NIV success

3. Immediate BiPAP availability: Have at bedside pre-extubation for high-risk patients

4. CPAP data download: Access cloud-based compliance data with patient consent

5. Reverse Trendelenburg positioning: For morbidly obese ARDS patients

6. Acetazolamide adjunct: During ventilator weaning in OHS patients

7. Device magnet: Keep available to turn off hypoglossal stimulators

---

Conclusions

Obstructive sleep apnea represents a highly prevalent comorbidity in critically ill patients with far-reaching implications for airway management, mechanical ventilation, cardiovascular stability, and overall outcomes. Recognition and appropriate management of OSA in the ICU setting requires a systematic approach encompassing:

1. High index of suspicion and active screening using validated tools
2. Anticipation of difficult airway with appropriate preparation and expertise
3. Optimized mechanical ventilation strategies with higher PEEP requirements
4. Careful sedation and analgesia management emphasizing multimodal opioid-sparing approaches
5. Strategic extubation planning with immediate post-extubation respiratory support
6. Aggressive PAP therapy resumption or initiation as soon as clinically feasible

The intensivist must recognize that OSA is not merely a sleep disorder but a systemic condition affecting multiple organ systems. Management extends beyond the mechanics of positive pressure therapy to encompass cardiovascular optimization, metabolic control, and neurological protection.

As our understanding of OSA pathophysiology advances and new therapies emerge, the critical care approach must evolve from reactive management of complications to proactive risk stratification and preventive strategies. Implementation of evidence-based protocols, multidisciplinary team approaches, and judicious use of monitoring technology can significantly reduce OSA-associated morbidity in our most vulnerable patients.

---

References

1. Chung F, Abdullah HR, Liao P. STOP-BANG Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea. Chest. 2016;149(3):631-638.

2. Memtsoudis SG, Stundner O, Rasul R, et al. Sleep Apnea and Total Joint Arthroplasty Under Various Types of Anesthesia: A Population-Based Study of Perioperative Outcomes. Reg Anesth Pain Med. 2013;38(4):274-281.

3. Liao P, Yegneswaran B, Vairavanathan S, Zilberman P, Chung F. Postoperative Complications in Patients with Obstructive Sleep Apnea: A Retrospective Matched Cohort Study. Can J Anaesth. 2009;56(11):819-828.

4. Gali B, Whalen FX, Schroeder DR, Gay PC, Plevak DJ. Identification of Patients at Risk for Postoperative Respiratory Complications Using a Preoperative Obstructive Sleep Apnea Screening Tool and Postanesthesia Care Assessment. Anesthesiology. 2009;110(4):869-877.

5. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased Prevalence of Sleep-Disordered Breathing in Adults. Am J Epidemiol. 2013;177(9):1006-1014.

6. Loadsman JA, Hillman DR. Anaesthesia and sleep apnoea. Br J Anaesth. 2001;86(2):254-266.

7. Chung F, Memtsoudis SG, Ramachandran SK, et al. Society of Anesthesia and Sleep Medicine Guidelines on Preoperative Screening and Assessment of Adult Patients With Obstructive Sleep Apnea. Anesth Analg. 2016;123(2):452-473.

8. Gross JB, Bachenberg KL, Benumof JL, et al. Practice Guidelines for the Perioperative Management of Patients with Obstructive Sleep Apnea: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep Apnea. Anesthesiology. 2014;120(2):268-286.

9. Squadrone V, Coha M, Cerutti E, et al. Continuous Positive Airway Pressure for Treatment of Postoperative Hypoxemia: A Randomized Controlled Trial. JAMA. 2005;293(5):589-595.

10. Jaber S, Delay JM, Chanques G, et al. Outcomes of Patients With Acute Respiratory Failure After Abdominal Surgery Treated With Noninvasive Positive Pressure Ventilation. Chest. 2005;128(4):2688-2695.

11. Carrera M, Barbe F, Sauleda J, et al. Patients with Obstructive Sleep Apnea Exhibit Genioglossus Dysfunction That is Normalized After Treatment with Continuous Positive Airway Pressure. Am J Respir Crit Care Med. 1999;159(6):1960-1966.

12. Mokhlesi B, Masa JF, Brozek JL, et al. Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019;200(3):e6-e24.

13. Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-Airway Stimulation for Obstructive Sleep Apnea. N Engl J Med. 2014;370(2):139-149.

14. Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining Phenotypic Causes of Obstructive Sleep Apnea. Identification of Novel Therapeutic Targets. Am J Respir Crit Care Med. 2013;188(8):996-1004.

15. Taranto-Montemurro L, Messineo L, Sands SA, et al. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial. Am J Respir Crit Care Med. 2019;199(10):1267-1276.

16. Khanna AK, Bergese SD, Jungquist CR, et al. Prediction of Opioid-Induced Respiratory Depression on Inpatient Wards Using Continuous Capnography and Oximetry: An International Prospective, Observational Trial. Anesth Analg. 2020;131(4):1012-1024.

17. Adesanya AO, Lee W, Greilich NB, Joshi GP. Perioperative Management of Obstructive Sleep Apnea. Chest. 2010;138(6):1489-1498.

18. Opperer M, Cozowicz C, Bugada D, et al. Does Obstructive Sleep Apnea Influence Perioperative Outcome? A Qualitative Systematic Review for the Society of Anesthesia and Sleep Medicine Task Force on Preoperative Preparation of Patients with Sleep-Disordered Breathing. Anesth Analg. 2016;122(5):1321-1334.

19. Subramani Y, Singh M, Wong J, Kushida CA, Malhotra A, Chung F. Understanding Phenotypes of Obstructive Sleep Apnea: Applications in Anesthesia, Surgery, and Perioperative Medicine. Anesth Analg. 2017;124(1):179-191.

20. Hoshijima H, Mihara T, Maruyama K, Denawa Y, Mizuta

K, Takayama K. Recovery profiles after ambulatory anesthesia in adult patients with obstructive sleep apnea: a systematic review and meta-analysis. J Clin Anesth. 2018;49:23-33.

21. Fernandez-Bustamante A, Frendl G, Sprung J, et al. Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic Surgery: A Multicenter Study by the Perioperative Research Network Investigators. JAMA Surg. 2017;152(2):157-166.

22. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230-1235.

23. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122(4):352-360.

24. Gupta RM, Parvizi J, Hanssen AD, Gay PC. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case-control study. Mayo Clin Proc. 2001;76(9):897-905.

25. Memtsoudis SG, Liu SS, Ma Y, et al. Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg. 2011;112(1):113-121.

26. Chan MTV, Wang CY, Seet E, et al. Association of Unrecognized Obstructive Sleep Apnea With Postoperative Cardiovascular Events in Patients Undergoing Major Noncardiac Surgery. JAMA. 2019;321(18):1788-1798.

27. Kaw R, Chung F, Pasupuleti V, Mehta J, Gay PC, Hernandez AV. Meta-analysis of the association between obstructive sleep apnoea and postoperative outcome. Br J Anaesth. 2012;109(6):897-906.

28. Nagappa M, Mokhlesi B, Wong J, Wong DT, Kaw R, Chung F. The Effects of Continuous Positive Airway Pressure on Postoperative Outcomes in Obstructive Sleep Apnea Patients Undergoing Surgery: A Systematic Review and Meta-analysis. Anesth Analg. 2015;120(5):1013-1023.

29. Ramachandran SK, Pandit JJ, Devine S, Thompson A, Shanks A. Post-operative respiratory complications in patients at risk for obstructive sleep apnoea: a closed claims analysis. Anaesthesia. 2018;73(7):791-798.

30. Seet E, Chung F. Obstructive sleep apnea: preoperative assessment. Anesthesiol Clin. 2010;28(2):199-215.

31. Cavalcante AN, Sprung J, Schroeder DR, Weingarten TN. Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression. Anesth Analg. 2017;125(1):141-146.

32. Ankichetty S, Wong J, Chung F. A systematic review of the effects of sedatives and anesthetics in patients with obstructive sleep apnea. J Anaesthesiol Clin Pharmacol. 2011;27(4):447-458.

33. Pawlik MT, Hansen E, Waldhauser D, Selig C, Kuehnel TS. Clonidine premedication in patients with sleep apnea syndrome: a randomized, double-blind, placebo-controlled study. Anesth Analg. 2005;101(5):1374-1380.

34. Doufas AG, Tian L, Padrez KA, et al. Experimental Pain and Opioid Analgesia in Volunteers at High Risk for Obstructive Sleep Apnea. PLoS One. 2013;8(1):e54807.

35. Bolden N, Smith CE, Auckley D, Makarski J, Avula R. Perioperative complications during use of an obstructive sleep apnea protocol following surgery and anesthesia. Anesth Analg. 2007;105(6):1869-1870.

36. Weingarten TN, Flores AS, McKenzie JA, et al. Obstructive sleep apnoea and perioperative complications in bariatric patients. Br J Anaesth. 2011;106(1):131-139.

37. Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med. 2004;116(1):1-7.

38. Carrillo A, Ferrer M, Gonzalez-Diaz G, et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(12):1279-1285.

39. Berry RB, Chediak A, Brown LK, et al. Best Clinical Practices for the Sleep Center Adjustment of Noninvasive Positive Pressure Ventilation (NPPV) in Stable Chronic Alveolar Hypoventilation Syndromes. J Clin Sleep Med. 2010;6(5):491-509.

40. Masa JF, Corral J, Alonso ML, et al. Efficacy of Different Treatment Alternatives for Obesity Hypoventilation Syndrome. Pickwick Study. Am J Respir Crit Care Med. 2015;192(1):86-95.

41. Murphy PB, Davidson C, Hind MD, et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax. 2012;67(8):727-734.

42. Randerath W, Verbraecken J, Andreas S, et al. European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea. Eur Respir Rev. 2021;30(162):210200.

43. Edwards BA, Andara C, Landry S, et al. Upper-Airway Collapsibility and Loop Gain Predict the Response to Oral Appliance Therapy in Patients With Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2016;194(11):1413-1422.

44. Sunnergren O, Broström A, Svanborg E. Soft Palate Surgery May Improve Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. Laryngoscope. 2019;129(6):1483-1492.

45. Kezirian EJ, Hohenhorst W, de Vries N. Drug-induced sleep endoscopy: the VOTE classification. Eur Arch Otorhinolaryngol. 2011;268(8):1233-1236.

46. Boyd SB, Walters AS, Song Y, Wang L. Comparative Effectiveness of Maxillomandibular Advancement and Uvulopalatopharyngoplasty for the Treatment of Moderate to Severe Obstructive Sleep Apnea. J Oral Maxillofac Surg. 2013;71(4):743-751.

47. Heiser C, Steffen A, Boon M, et al. Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry. Eur Respir J. 2019;53(1):1801405.

48. Schwartz AR, Barnes M, Hillman D, et al. Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med. 2012;185(4):420-426.

49. Eastwood PR, Barnes M, Walsh JH, et al. Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep. 2011;34(11):1479-1486.

50. Schwartz M, Acosta L, Hung YL, Padilla M, Enciso R. Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep Breath. 2018;22(3):555-568.

---

Key Management Algorithms

Algorithm 1: Preoperative OSA Risk Stratification

Patient scheduled for surgery
         ↓
Known OSA diagnosis? → YES → Obtain CPAP settings/compliance data
         ↓ NO                        ↓
Apply STOP-BANG Score          Severe OSA (AHI >30)?
         ↓                              ↓
Score ≥ 3? → NO → Standard care   YES → High Risk Protocol
         ↓ YES                          ↓
Physical exam:                    - ICU/monitored bed
- Mallampati III/IV?              - Multimodal analgesia
- Neck circ >43cm (M)/41cm (F)?   - Prophylactic NIV
- BMI >35?                        - Extended monitoring
         ↓                              ↓
≥2 features? → YES → Intermediate Risk    NO → Moderate Risk
         ↓ NO                              ↓
Standard enhanced recovery          - PACU extended stay
                                   - Continuous pulse ox
                                   - CPAP resumption

Algorithm 2: Post-Extubation Respiratory Support in OSA

OSA patient ready for extubation
         ↓
Risk assessment:
- BMI >40?
- AHI >30?
- OHS diagnosis?
- Prolonged intubation (>48h)?
         ↓
HIGH RISK (≥2 factors)        LOW-MODERATE RISK
         ↓                              ↓
Pre-extubation optimization:    Standard extubation protocol
- Diuresis to euvolemia              ↓
- HOB 45 degrees                Monitor for 2 hours
- Pain control optimized             ↓
         ↓                      Signs of distress?
Have BiPAP at bedside               ↓ YES
         ↓                           ↓
Extubate → Immediate BiPAP    Initiate CPAP/BiPAP
(IPAP 12-15, EPAP 8-10)              ↓
         ↓                      If known CPAP user:
Wean as tolerated over 24-48h   Use home settings
If stable → transition to        ↓
nocturnal CPAP only         Monitor continuous SpO₂ × 24h

Algorithm 3: NIV Troubleshooting

NIV initiated but patient struggling
         ↓
Identify primary problem:
         ↓
┌────────┴────────────────────────┐
↓                                  ↓
Large air leak                Claustrophobia/anxiety
↓                                  ↓
- Check mask fit              - Start short intervals
- Try different mask style    - Use mirror
- Ensure not over-tightened   - Consider anxiolysis
- Check mouth closure         - Try nasal pillows
         ↓                              ↓
┌────────┴────────┐          Patient-ventilator dyssynchrony
↓                  ↓                    ↓
Pressure intolerance    Aerophagia    - Adjust trigger sensitivity
↓                          ↓           - Increase rise time
- Use ramp feature    - Reduce IPAP   - Check for auto-triggering
- Lower starting P    - Anti-gas meds - Consider different mode
- Try APAP mode       - HOB elevation       ↓
         ↓                  ↓           Persistent failure?
Nasal congestion/dryness    ↓                ↓
         ↓              If all measures fail:  Consider:
- Heated humidification     ↓           - High-flow nasal oxygen
- Saline spray         Re-evaluate need - Reintubation if severe
- Decongestants        for NIV vs.     - Tracheostomy if prolonged
                       reintubation

---

Special Considerations by Surgical Subspecialty

Cardiac Surgery

Unique challenges:

• Highest OSA prevalence (60-80%)
• Atrial fibrillation risk markedly increased
• Sternal pain limits cough effectiveness
• Fluid shifts common

Management pearls:

• Prophylactic NIV post-extubation reduces AF by 30-40%
• Early mobilization critical (reduces atelectasis)
• Regional analgesia (thoracic epidural, paravertebral blocks) superior to systemic opioids
• Monitor for hypoglossal nerve injury (rare but prevents tongue protrusion)

Bariatric Surgery

Unique challenges:

• Near-universal OSA (70-90%)
• Many patients have undiagnosed OHS
• Anatomic challenges persist immediately post-op
• Risk of anastomotic leak increased with hypoxemia

Management pearls:

• Mandatory preoperative sleep study in most bariatric programs
• Enhanced recovery protocols essential
• Never fully supine—minimum 30-degree elevation
• Early ambulation (within 4-6 hours)
• Consider routine ICU admission for super-obesity (BMI >60)

Oyster: Bariatric surgery actually improves or resolves OSA in 75-85% of patients within 6-12 months. Long-term follow-up sleep studies are essential as CPAP requirements decrease, and some patients can discontinue therapy entirely.

Orthopedic Surgery (Total Joint Arthroplasty)

Unique challenges:

• Regional anesthesia common but doesn't eliminate OSA risk
• Opioid requirements traditionally high
• Immobility post-operatively
• VTE risk overlaps with OSA population

Management pearls:

• Spinal/epidural anesthesia reduces but doesn't eliminate respiratory complications
• Aggressive multimodal analgesia reduces opioid needs by 60-70%
• Peripheral nerve blocks (femoral, sciatic, adductor canal) excellent opioid-sparing
• VTE prophylaxis essential (OSA independent risk factor)

Neurosurgery

Unique challenges:

• Need for frequent neurological assessments
• Intracranial pressure considerations
• Positioning restrictions (posterior fossa cases)
• Airway edema post-prolonged surgery

Management pearls:

• Lower threshold for continued intubation post-operatively
• BiPAP can increase ICP—monitor if used
• Dexmedetomidine allows neurological assessment while maintaining sedation
• Consider early tracheostomy for prolonged ventilation needs

Head and Neck Surgery

Unique challenges:

• Airway edema expected
• Surgical manipulation of upper airway structures
• Hematoma risk
• May not tolerate masks if facial surgery

Management pearls:

• Consider tracheostomy for extensive oropharyngeal reconstruction
• High-flow nasal oxygen alternative if masks not tolerated
• Aggressive edema management (steroids, diuresis, head elevation)
• Extended intubation often safer than premature extubation

---

Quality Improvement Initiatives

Implementing an OSA Protocol in Your ICU

Step 1: Identify the Problem

• Audit current practices
• Determine OSA prevalence in your population
• Identify complications attributable to OSA
• Benchmark against national standards

Step 2: Develop the Protocol

Core elements:

1. Screening component

   • STOP-BANG at admission
   • Documentation in EHR

2. Risk stratification

   • Low/intermediate/high risk categories
   • Triggers for escalation

3. Monitoring standards

   • Continuous pulse oximetry criteria
   • Frequency of assessments
   • Alert parameters

4. Intervention bundle

   • CPAP/BiPAP availability
   • Multimodal analgesia order sets
   • Positioning protocols
   • Respiratory therapy consultation triggers

5. Education component

   • Nursing education
   • Physician education
   • Patient/family education materials

Step 3: Implementation

Champions approach:

• Identify physician and nursing champions
• Phased rollout (pilot unit → full implementation)
• Feedback loops
• Regular team meetings

Technology integration:

• EMR-based screening tools
• Auto-populated order sets
• Clinical decision support
• Compliance tracking dashboards

Step 4: Measure and Improve

Key metrics:

• Screening rate (goal: >90%)
• CPAP compliance in known OSA patients (goal: >80%)
• Reintubation rates
• ICU length of stay
• Respiratory complication rates
• Opioid consumption (MME/day)

Pearl: Start with one high-volume surgical population (e.g., orthopedics or bariatrics) to demonstrate proof-of-concept before ICU-wide implementation. Early wins build momentum and buy-in.

Cost-Effectiveness Considerations

OSA protocols may seem resource-intensive but demonstrate significant cost savings:

Costs:

• NIV equipment and supplies: $50-150/patient
• Extended monitoring: $100-300/day
• Additional respiratory therapy time: $50-100/day

Savings:

• Avoided reintubations: $10,000-50,000 per event
• Reduced ICU length of stay: $2,000-5,000/day
• Avoided complications: $5,000-100,000 per event
• Reduced medicolegal risk: Difficult to quantify but substantial

Net effect: Most studies show cost savings of $1,500-5,000 per high-risk patient managed with protocol.

---

Medicolegal Considerations

Documentation Essentials

Critical elements to document:

1. Preoperative assessment:

   • STOP-BANG or equivalent screening
   • Known OSA diagnosis and treatment
   • CPAP compliance if applicable
   • Anesthesia consultation if high-risk

2. Informed consent discussion:

   • Increased perioperative risks discussed
   • Options for risk mitigation
   • Patient preferences regarding monitoring/ICU admission

3. Intraoperative management:

   • Airway management details
   • Anesthetic technique choices (regional vs general)
   • Analgesic plan

4. Postoperative orders:

   • Monitoring level specified
   • CPAP/BiPAP orders
   • Opioid prescribing rationale
   • Escalation criteria

Pearl: The phrase "perioperative risks discussed including but not limited to respiratory depression, reintubation, cardiovascular events, and ICU admission" should appear in preoperative notes for identified OSA patients. This demonstrates informed consent.

Common Liability Scenarios

Scenario 1: Unrecognized OSA → Respiratory Arrest

• Patient not screened preoperatively
• Excessive opioids prescribed
• No enhanced monitoring
• Delayed recognition of respiratory depression

Prevention:

• Universal screening protocols
• Pulse oximetry monitoring
• Multimodal analgesia
• Nursing education on recognition

Scenario 2: Premature Extubation

• High-risk OSA patient extubated without support plan
• No CPAP/BiPAP available
• Reintubation required
• Complications from emergency reintubation

Prevention:

• Structured extubation protocols
• Prophylactic NIV
• Equipment at bedside
• Daytime extubation when possible

Scenario 3: Known OSA, CPAP Not Resumed

• Patient with home CPAP
• Device not brought to hospital or not used
• No alternative support provided
• Complications ensue

Prevention:

• Encourage patients to bring devices
• Hospital CPAP available if home device unavailable
• Clear orders for CPAP use
• Compliance monitoring

---

Patient and Family Education

Key Messages for OSA Patients

Preoperative discussion points:

1. "Your sleep apnea increases surgical risks, but we have a plan to minimize them"

   • Acknowledge concern while providing reassurance
   • Explain specific measures being taken

2. "Bring your CPAP machine to the hospital"

   • Use immediately after surgery
   • Nursing staff trained to assist
   • Better outcomes with early use

3. "Pain control will be different"

   • Emphasize multimodal approach
   • Explain rationale for limiting opioids
   • Set realistic expectations

4. "You may need closer monitoring"

   • ICU or monitored bed
   • Not because surgery went poorly
   • Proactive prevention strategy

5. "Positioning matters"

   • Head of bed elevated at all times
   • May not be allowed to lie flat
   • Helps with breathing

Written Materials

Provide patient handouts covering:

• What is OSA and why it matters for surgery
• Preoperative preparation checklist
• What to expect postoperatively
• Signs/symptoms to report
• CPAP use instructions
• Follow-up care

Hack: Create a "OSA Surgery Checklist" laminated card patients can bring to hospital:

□ CPAP machine and supplies packed
□ List of current medications
□ Sleep study results (if available)
□ Usual CPAP settings written down
□ Questions for surgical team
□ Plan for pain control discussed
□ Understanding of monitoring plan
□ Family member aware of OSA diagnosis

This simple tool improves patient preparation and engagement significantly.

---

Future Directions and Research Needs

Knowledge Gaps

Despite extensive literature, several questions remain:

1. Optimal CPAP/BiPAP settings in acute illness:

   • Home settings may not be appropriate
   • Fluid status, positioning, and inflammation alter requirements
   • Auto-titrating algorithms may not work in ICU environment

2. Duration of enhanced monitoring:

   • How long is continuous pulse oximetry necessary?
   • Can we identify low-risk periods for monitoring discontinuation?
   • Cost-effectiveness of various monitoring durations

3. Role of emerging therapies:

   • Pharmacological agents (atomoxetine/oxybutynin combination)
   • Applicability in perioperative period
   • Interaction with anesthetics and analgesics

4. Phenotype-specific management:

   • Can we tailor ICU management based on OSA phenotype?
   • Different approaches for anatomical vs physiological OSA?
   • Precision medicine applications

5. Long-term outcomes:

   • Does perioperative OSA management affect long-term cardiovascular outcomes?
   • Impact on cognitive function post-ICU
   • Quality of life metrics

Ongoing Clinical Trials

Several trials are investigating:

• Prophylactic vs rescue NIV strategies
• Optimal timing of CPAP resumption
• Novel analgesic regimens in OSA populations
• Telemedicine-based postoperative monitoring
• Hypoglossal nerve stimulation in perioperative period

Pearl: Encourage participation in clinical trials when available. High-quality evidence will ultimately improve care for all OSA patients undergoing surgery and critical illness.

---

Conclusion

Obstructive sleep apnea in critically ill patients represents a complex interplay of anatomical predisposition, physiological derangement, and iatrogenic factors. The modern intensivist must approach OSA not as an isolated sleep disorder but as a multisystem condition requiring comprehensive perioperative management.

Success requires:

• Vigilance in screening and identification
• Preparation for anticipated challenges
• Protocols to standardize evidence-based care
• Communication across multidisciplinary teams
• Education of patients, families, and staff
• Advocacy for resources and systems changes

As our population becomes increasingly obese and OSA prevalence rises, these skills will become ever more essential to critical care practice. The intensivist who masters OSA management will significantly improve outcomes for a large and growing patient population.

The pearls, oysters, and hacks presented in this review represent distilled clinical wisdom, but should be adapted to individual patient circumstances and local practice patterns. Evidence continues to evolve, and clinicians must remain current with emerging literature while maintaining the fundamental principles of anticipation, preparation, and meticulous perioperative care that define excellence in critical care medicine.

---

Conflicts of Interest: None declared

Acknowledgments: The author thanks the respiratory therapy, nursing, and anesthesiology colleagues whose collaborative care of OSA patients informed these recommendations.

---